Search

everythinglearnresearchcommunity

for

Search:↓

Newer low-dose oral contraceptives with less androgenic effects improve patient compliance.

Minoxidil and finasteride can help with hair loss, but more research is needed to improve treatments for certain types of hair loss.

The N363S gene variant does not cause higher adrenal androgen levels in women with polycystic ovary syndrome.

The document concludes that diagnosing PCOS in teenagers is difficult and should focus on specific hormone levels and menstrual irregularities, while also considering treatment for symptoms and related health issues.

The document concludes that treatments for female hair loss and excessive hair growth are temporary and not well-studied.

Men are getting more facial fillers, and doctors should use different techniques and fillers for men's unique facial features to get natural results.

Acne is caused by multiple factors including oil production, bacteria, inflammation, and possibly diet and environment.

The document explains different hair loss types and treatments, emphasizing diagnosis through examination and tests, and specific treatments for each condition.

Polycystic Ovary Syndrome (PCOS) often leads to severe acne, and lifestyle changes and hormonal treatments can help manage it.

Finasteride treats hair loss but may cause low libido, erectile issues, and depression.

Early-onset baldness is linked to genetics, lifestyle, and can indicate higher risk for heart and metabolic diseases, and affects mental health.

Women with PCOS are more vulnerable to severe COVID-19 and related health issues.

Different hair disorders have specific treatments and outcomes, with some resolving on their own and others requiring medication or emotional support.

Hirsutism is often caused by high male hormone levels and can be treated with lifestyle changes and medications.

The conclusion is that thorough investigation of hypertension and hormonal dysfunctions is important, and there may be a link between these conditions and cancer.

People with androgenetic alopecia, both men and women, are more likely to develop heart diseases in the future.

Finasteride and dutasteride can cause severe, lasting side effects.

Hormonal interactions, especially involving DHT and estrogen, play a key role in BPH development and treatment.

Spironolactone is safe for treating female hair loss, but the safety of other drugs is uncertain.

Men who start losing hair at age 30 may have a lower risk of prostate cancer.

The document concludes that a systematic approach is crucial to identify causes of androgen excess in women beyond the most common cause, Polycystic ovary syndrome (PCOS).

The article suggests renaming Polycystic Ovarian Syndrome (PCOS) to "Hyperandrogenic Persistent Ovulatory Dysfunction Syndrome" (HA-PODS) for accuracy and consistency, but no final decision was made.

The conclusion is that women under 35 should start fertility checks after 12 months of trying to conceive, women over 35 after 6 months, and women over 40 should start immediately. The checks should include ovulation status, reproductive tract structure, and male partner's semen evaluation.

The conclusion is that obesity should be managed with a slow, balanced approach to diet and exercise, with medication and surgery as additional options, and education and access to care are important.

Hair loss due to scarring can be treated by reducing inflammation, removing scar tissue, and transplanting hair. The Follicular Unit Extraction technique is effective but requires skill and time. Future focus should be on scar-less healing methods.

Women with androgenetic alopecia (hair loss) have normal prostate specific antigen levels but higher testosterone levels.

Blood AMH levels are higher in women with PCOS than in those with other similar conditions.

Daily subcutaneous testosterone effectively restores testosterone levels in men.

High uric acid levels are more common in PCOS patients, especially those with androgenic PCOS, and are linked with increased cardiovascular risk and other metabolic issues.